Introduction
Adult T-cell leukemia/lymphoma (ATLL) is a peripheral CD4 + T-cell malignancy caused by infection with human T-lymphotropic virus-1 (HTLV-1). 1 HTLV-1 infection is endemic in a number of well-defined geographical regions within Japan, and as many as 20 million individuals worldwide are estimated to harbor it. 2 ATLL occurs after a prolonged latency period of up to 50 years in approximately 5% of individuals who have been infected with HTLV-1 around the time of birth. HTLV-1 encodes a trans-activator, Tax, which plays a key role in the polyclonal growth of infected T cells through the activation of various genes. 3 However, recent studies have shown that Tax expression is undetectable in circulating ATLL cells, while a genetically and epigenetically defective provirus was observed in more than half of the ATLL patients examined. 4, 5 Considering the long latency period of ATLL, it has been proposed that at least 5 additional genetic or epigenetic events are required for the development of overt disease. 1, 6 Nonrandom chromosomal translocations are considered to cause leukemic transformation, including structural and/or quantitative abnormalities of transcription factors such as AML1, EVI1 and MLL. 7 To identify disease-specific chromosomal translocations in ATLL, karyotypes of 107 ATLL cases determined by the G-banding method were reviewed in Japan. 8 There was a high degree of diversity and complexity, and disease-specific translocations were not found; however, translocations involving 14q32 (28%) or 14q11 (14%) and the deletion of 6q (23%) were the most frequent chromosomal abnormalities. 8 Recently, chromosome-based comparative genomic hybridization (CGH) 9 and BAC array-based CGH showed complex chromosomal abnormalities with gains in 1q, 2p, 4q, 7p, and 7q, and losses in 10p, 13q, 16q, and 18p. 10 To date, however, no gene involved in the development of ATLL has been isolated.
Array CGH is useful for detecting genomic deletions or amplifications, but it cannot detect chromosomal translocations or inversions.
In this study, we searched for the existence of recurrent chromosomal rearrangements by multicolor spectral karyotyping (SKY) and high-resolution single nucleotide polymorphism (SNP) array-CGH (SNP array-CGH). We precisely mapped 605 chromosomal breakpoints in 61 ATLL cases. Breakpoints occurred most frequently in 10p11 and were mapped within a 1-Mb region in 10p11.2 with heterozygous deletions only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013 . bloodjournal.hematologylibrary.org From in all cases. A minimal common region of chromosome deletions, including a region of homozygous deletion, was mapped to a 2-Mb region. Genetic and expression analyses of the genes mapped within the deleted region revealed transcription factor 8 (TCF8) to be frequently altered in ATLL cells by several mechanisms, mainly including epigenetic dysregulation, suggesting that TCF8 may be a candidate tumor suppressor gene. TCF8 (GenBank accession number, NM 030751), AREB6, ZFHEP, NIL-2A, ZFHX1A, NIL-2-A, MGC133261 or ZEB1 encodes a two-handed zinc finger homeodomain protein, 11 which represents a key player in pathologic associated with tumor progression in solid cancers. 12, 13 In this study, we found that TCF8-mutant mice frequently developed CD4 + T-cell lymphoma/leukemia half a year after birth. Furthermore, we showed that down-regulation of TCF8 expression in ATLL cells in vitro was associated with TGF-β1 resistance, a well-known characteristic of ATLL cells, suggesting that escape from TGF-β1-mediated growth inhibition is one of primary mechanisms in the pathogenesis of ATLL. These findings suggest that TCF8 has an important tumor suppressor role in ATLL.
Materials and Methods

Patient samples
ATLL cells were collected from patients at the time of admission to hospital and before chemotherapy. 
Cell lines
only.
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14 Briefly, 4 of the cell lines, Jurkat, MOLT4, MKB1 and KAWAI are HTLV-1-negative human T-cell acute lymphoblastic leukemia (T-ALL) cell lines. 16, 17 Three cell lines, KOB, SO4 and KK1
are interleukin 2 (IL2)-dependent ATLL cell lines. 18 ED, Su9T and S1T are IL2-independent ATLL cell lines.
19
MT2 and HUT102 are human T-cell lines transformed by HTLV-1 infection. 20 CTLL2 is a murine IL-2-dependent T-lymphoma cell line. 21 All the cell lines were maintained in PRMI1640 medium supplemented with 10% fetal calf serum (FCS) and with or without IL2.
Cell culture and karyotype analysis
G-banding studies were performed as described previously. 8 Briefly, leukemia cells were diluted in 10 mL of RPMI1640 medium supplemented with 10% FCS at a final concentration of 1 x 10 6 cells/mL. The cells were cultured at 37˚C for 24-48 hours in humidified air with 5% CO 2 , exposed to colcemid (0.05 mg/mL) for 60 minutes, 
Spectral karyotyping (SKY) and DAPI banding analysis
Strategy of combined spectral karyotyping (SKY) and 4, 6-diaminido-2-phenylindole dihydrochloride (DAPI) banding analysis of chromosome abnormalities were published 22 and briefly described as follows: The chromosomes prepared on a slide glass were denatured and hybridized with a cocktail probe mixture for 2 days at 37˚C. The SKY probe mixture and hybridization reagents were purchased from Applied Spectral Imaging
Inc. (Vista, CA), and signal detection was performed according to the manufacturer's protocol. The chromosomes were counterstained with DAPI combined with an anti-fade solution (Vectaschield; Vector Laboratories, Burlingame, CA). Images were acquired by means of an SD200 Spectracube (Applied Spectral Imaging) mounted on an Olympus BX50-RF (Olympus, Tokyo, Japan) using a custom-designed optical filter (SKY-1;
Chroma Technology, San Diego, CA). With another special optical filter, the inverted DAPI images were captured in conjunction with spectral classifications as QFH band only.
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Fluorescence in situ hybridization (FISH) analysis
The plasmid library from sorted human chromosomes 10 (pBS10) was used as a whole chromosome painting (WCP) probe, labeled with digoxigenin-16-dUTP (Boehringer-Ingelheim, Ingelheim, Germany) by standard nick translation. BAC clones were labeled with biotin-16-dUTP (Sigma). Hybridization and signal detection were performed as described previously. 23 A minimum of 50 nuclei was examined for each FISH. FISH analysis was performed on metaphase and interphase chromosomes by 53
BAC clones mapped to the chromosome bands 10p11-12 in the human genome mapping of NCBI (build 36 version 1) as probes.
High density SNP array comparative genomic hybridization (array-CGH) analysis
Total genomic DNA was digested with XbaI, ligated to an adaptor, and subjected to PCR amplification using a single primer. For data normalization, we used 6 normal reference samples. Genomic location of probes on the array was determined with the information in NCBI genome map build 35.1.
Mice
C57BL/6 and ICR mice were purchased from CLEA Japan Inc (Tokyo, Japan) and maintained under specific pathogen-free conditions. The targeted allele of the δEF1 gene, the murine orthologue of TCF8, lacks only the COOH-proximal zinc finger cluster domain. 25 Approximately 20% of the homozygous TCF8-mutant mice were born alive and grew up to adulthood, though it was reported to cause a defect in the thymic T cell development. 25, 26 To produce viable homozygous TCF8-mutant mice, we made their genetic backgrounds more heterogeneous by crossing the C57BL/6 background only.
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Assay for cell proliferation
Control siRNA was purchased from Qiagen (Valencia, CA) (AllStars Negative Control
[ANC] siRNA) and the TCF8 siRNA was from Ambion (Austin, TX) (murine TCF8; 
Results
Identification of a common hemizygous deletion in 10p11 in ATLL by mapping chromosomal breakpoints
We recently studied recurrent chromosomal rearrangements in adult T-cell leukemia lymphoma (ATLL) cells from 61 patients by spectral karyotyping (Hidaka et al, in preparation). In examining the molecular changes in ATLL cells, 605 chromosomal breakpoints in 61 cases were identified and precisely mapped by DAPI banding analysis.
The frequency of the breakpoints was counted in each region of the chromosomes, with an average of around 10 translocations in each case ( Figure 1A ). Most of the chromosomal translocations were unbalanced, and a few recurrent reciprocal translocations were found. Chromosomal breakages were most frequently identified at 10p11 (21 out of 61 cases, 34.6%) and they were also frequently represented at 14q11 and 14q32 regions ( Figure 1A ). Based on the data of SKY, these three events occurred almost only.
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Therefore, we precisely mapped the chromosomal breakpoints at 10p11 in three ATLL cell lines (KK1, KOB, and SO4) and two primary ATLL cases (ATL018 and ATL090) by fluorescence in situ hybridization (FISH). We identified der(10)t(10;22)(p11.2;q13.1) in KK1, der(10)t(10;14)(p11.2;q11.2) in KOB, der(10)t(2;10)(p23;p11.2) in SO4, t(10;21)(p11.2;q11.2) in ATL018, and t(10;13)(p11.2;q14) in ATL090 (Table S1 ). Using 53 BAC clones on 10p as DNA probes for FISH (Table S2) , the chromosomal breakpoints in these five cases were mapped to a 1-Mb region at 10p11.2 ( Figure 1B ). It was noted that the genomic deletions surrounding the chromosomal breakpoints were detected by a FISH analysis ( Figure 1C) and heterozygous deletions of the 10p11.2 region with translocations were found in all five samples (Table S2 and Figure 1B To confirm these results, we performed SNP array-CGH using DNA from eight ATLL-related cell lines including KK1, KOB, SO4, and an additional 10 samples from acute-type ATLL patients. Deletions in 10p11.2, including the 2-Mb deletion region, were noted in three cell lines: KK1, KOB, and SO4, and an additional four patient samples ( Figure 1B and Table S3 ). Using SNP array-CGH, the telomeric deleted regions in chromosome 10p11.2 in KOB and KK1 covered a wider area than those detected by FISH analysis, and each deleted region in the three cell lines and four patients samples covered the common deletion region. To combine these data, the same minimal common region of chromosome deletions, including regions of homozygous deletion in ATL090, was mapped to a 2-Mb region from PR11-523J14 to RP11-342D11 ( Figure 1B 
Down-regulation of TCF8 mRNA in ATLL cells
We examined the mRNA expression profiles of all 12 genes within the commonly deleted region in 10p11.2, which were identified by NCBI and Celera gene maps. Since mRNA samples from the ATLL patients used for the deletion mapping were not available, we initially used the mRNA expression profiles of the other eight leukemia cell samples from acute-type ATLL patients by semi-quantitative reverse-transcription PCR (RT-PCR), which had been previously identified by DNA microarray.
14 Two leukemia samples from patients with ATLL had chromosome 10p11.2 abnormalities: t(10;15)(p11.2;q26) in ATL044 and monosomy 10 in ATL009 (Table S1 ). Expression levels of eight genes (TCF8, ARHGAP12, KIF5B, CCDC7, EPC1, C10orf68, ITGB1 and NRP1) and HTLV-1
Tax as well as β-actin are shown in Figure 2A . The results showed that levels of TCF8 mRNA in ATLL cells had a tendency to be lower than those in CD4 + T lymphocytes from normal volunteers, even though only two of eight patients had chromosome 10p11. (Table 1 ). After treatment with TSA for 48 hours, the levels of TCF8 mRNA increased in seven of 10 cell lines (Jurkat, MT2, HUT102, ED, KK1, S1T and Su9T), also with over 3-fold activation (P < .05). In addition, combination therapy induced TCF8 mRNA expression in five cell lines by over 3-fold.
Therefore, TCF 8 mRNA expression was activated in seven of eight ATLL-related cell lines along with Jurkat cells by either 5-aza-dC or TSA treatment, suggesting that the down-regulation of TCF8 in most of the ATLL cell lines except SO4 cells with a chromosome 10p hemizygous deletion was dependent on epigenetic abnormalities.
Unmethylated putative TCF8 promoter in ATLL cell lines
Next, we determined the methylation status of the TCF8 promoter by bisulfite sequencing. A CpG island containing 50 CpGs was amplified from a 632-bp region of the putative TCF8 promoter adjacent to exon 1 using two pairs of PCR primers and bisulfite-treated genomic DNA from three ATLL cell lines: ED, KOB, and KK1.
However, the TCF8 promoter was not methylated in any of the three ATLL cell lines in which TCF8 expression was induced by 5-aza-dC ( Figure 3A) , suggesting that the CpG island was not a direct target for DNA methylation in ATLL cells. Moreover, TCF8 mRNA was up-regulated in various ATLL cell lines after treatment with hydralazine, which was reported to decrease DNA methyltransferase expression ( Figure S3 ). This observation suggests that a transactivating regulator of TCF8 may be modulated by methylation or the other regulatory elements are located outside the TCF8 promoter.
Such enhancer-related methylation events have been described for the imprinting of H19 and Igf2, p21WAF1 regulation by p73, and Apaf-1.
27-30 Therefore, further analyses will be needed to determine the exact regulatory element near the TCF8 gene or to find a transactivating regulator of TCF8, that is directly methylated in ATLL cells.
For
Histone deacetylation is directly involved in down-regulation of TCF8 mRNA expression in ATLL cells
To confirm the correlation between reduced TCF8 mRNA expression and histone deacetylation, TCF8 expression and histone acetylation status were analyzed in the ATLL-related cell lines (MT2, HUT102, ED and KK1) by chromatin immunoprecipitation (ChIP) after treatment with or without TSA. After treatment with TSA for 48 hours, the chromosomal DNA precipitated by anti-acetylated histone H3 or H4 antibody was amplified with two sets of primers for the TCF8 promoter region or for the human β-actin promoter region ( Figure 3B ). Band intensities of the TCF8 promoter region in four cell lines were amplified 3 to 6-fold after treatment with TSA, indicating that histone deacetylation of the TCF8 promoter region was directly involved in the down-regulation of TCF8 mRNA expression in ATLL cells.
Identification of missense mutations in TCF8 in ATLL cells
We then searched for somatic TCF8 mutations in DNA samples from 34 patients with acute-type ATLL and 10 T-cell leukemia cell lines. Genomic PCR did not detect any homozygous deletions in any of the nine coding exons of TCF8 in these samples.
We detected five types of nucleotide substitutions, and all were heterozygous ( Figure 3C ).
The 255A>C substitution in HUT102, creating a missense mutation [Asn78Thr] in exon 2, and the 335T>C substitution in the leukemia cells from three ATLL patients, creating a missense mutation [Cys105Arg] in exon 3, were likely to be somatic mutations (Table   S4 ), since they were not detected in non-cancerous cells from 95 Japanese volunteers.
The above results indicate that the TCF8 gene is altered by several mechanisms, including hemizygous deletion, epigenetic dysregulation, and intragenic mutations.
Regarding the ATLL-related cell lines, three of nine showed hemizygous deletions of 10p11.2; eight of nine showed epigenetic dysregulation of the TCF8 gene; and one of nine showed an intragenic mutation (Table 1) . Therefore, TCF8 is a strong candidate tumor suppressor gene for ATLL leukemogenesis and is initially inactivated by unbalanced translocations with heterozygous deletion in the 10p11.2 region in ATLL cells.
Development of CD4 + T-cell lymphoma in TCF8 mutant mice
To determine whether down-regulation of the TCF8 gene could be a causative only.
For For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From mouse, the mononuclear cells that invaded the liver, as well as a majority of the cells that invaded the spleen, were DP T lymphoma cells ( Figure 5I ). Therefore, in the same mouse, both tumor cells derived from the thymus and those that had invaded the organs were revealed to be DP T lymphoma cells. Moreover, the remaining mice with large thymic tumors showed the same CD4 + CD8 + DP T lymphoma cells. In total, 84% of the T cell tumors in TCF8 homologous mutant mice could be classified as CD4+ SP T-cell lymphoma, and 16%, as CD4 + CD8 + DP thymic T-cell lymphoma. CD8+ SP T lymphomas were never observed. Thus, the histopathological and cellular findings revealed that CD4 + T-cell lymphoma/leukemia developed in most TCF8 mutant mice.
Down-regulation of TCF8 expression is associated with TGF-β1 resistance in ATLL cells
The TGF-β superfamily is known to inhibit the lineage commitment of double-positive (DP) cells towards CD4 + T-cell differentiation. For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From selection due to reduced TGF-β1 responsiveness.
Discussion
We demonstrated that in ATLL cells, the TCF8 gene was mainly epigenetically inactivated in a majority of ATLL cells.
In addition, TCF8 (or δEF1 
vivo.
39 Therefore, TCF8 has dual functions in cancer progression, which are dependent on the type of the tumors, such as WT1 or TSLC1 tumor suppressor genes. 40, 41 It was previously reported that TCF8-mutant mice had a defect in T cell development in the first week of life. 19 At the early stage of development, intrathymic c-kit + T precursor cells in these mice were depleted to just 1% of the level in normal mice, and the number of CD8 + SP T cells was significantly reduced relative to the number of CD4 + SP T cells. These observations indicate that TCF8 is involved in the regulation of T cell development at multiple stages. Lymphoma cells in TCF8-mutant mice showed either CD4 + SP T cells or DP T cells after six months. Interestingly, TGF-β1 was important for regulating T cell development in the thymus and for negative selection at the late stage of differentiation of DP T cells to CD4 + SP cells. 31 Recently, DNA microarray analysis identified a higher level of TCF8 expression in DP thymocytes to CD4 + SP T cells, 42 suggesting that TCF8 enhanced negative selection due to TGF-β1 responsiveness. Moreover, TGF-β1-deficient mice had an increased number of CD4 + SP T cells and a decreased number of CD8 + SP T cells. 43, 44 By correlating the development of CD4 + SP T-lymphoma cells in TCF8-mutant mice with the increase in the number of CD4 + T cells in TGF-β1-deficient mice, we concluded that leukemogenesis in TCF8-mutant mice was partly dependent on resistance to TGF-β1.
TCF8
is an E-box-binding transcription factor reported to regulate many genes.
We found that the transcription of CD4, α4 integrin, and GATA-3, which was reported to be suppressed by TCF8, 45 was up-regulated in ATLL cells (data not shown). It was therefore suggested that impaired regulation of TCF8 expression in ATLL induced the increase in expression of CD4 and GATA3, which was crucial for the establishment of the ATLL phenotype in CD4 + SP helper T lymphocytes. Moreover, TCF8 was reported to regulate p73, CCNG2, or p130. 46, 47 Since these genes are very important for cell cycle progression and apoptosis, further investigation is needed to determine which ones are directly related to leukemogenesis among those regulated by TCF8.
The phenotypes of T-cell lymphomas in TCF8-mutant mice were very similar to those of ATLL patients. In TCF8-mutant mice, the tumor cells were mainly CD4 + SP or DP T cells, which invaded various organs, such as the liver, spleen, and lungs. In ATLL, the tumor cells were mainly CD4 + SP T cells that also invaded various organs. One difference, however, was that thymic lymphomas developed in the TCF8-mutant mice, which has not been reported in ATLL cases. Another difference is that lymphoma cells in TCF8-mutant mice did not have multi-lobulated nuclei. Such nuclei result from alterations in the PI3-kinase signaling cascades, 48 suggesting that down-regulation of TCF8 expression is not related to the PTEN signaling pathway and that other mutations are necessary for the development of ATLL. This is the first report illustrating the importance of the disruption of TCF8 in leukemogenesis of ATLL.
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